Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
OTONOMY, INC. (OTIC) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/04/2023 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
04/03/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/03/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/03/2023 EFFECT Form EFFECT - Notice of Effectiveness:
03/28/2023 8-K Quarterly results
02/14/2023 SC 13G/A Point72 Asset Management, L.P. reports a 0% stake in Otonomy, Inc.
02/13/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 0% stake in Otonomy, Inc.
01/30/2023 PRE 14A Form PRE 14A - Other preliminary proxy statements:
01/30/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
12/29/2022 8-K Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balan...
Docs: "Lease Termination Agreement"
12/29/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/29/2022 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/19/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
12/19/2022 8-K Quarterly results
11/18/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
11/14/2022 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in OTONOMY, INC.
10/24/2022 8-K Quarterly results
10/14/2022 8-K Results of Operations and Financial Condition  Interactive Data
09/16/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing  Interact...
09/09/2022 SC 13G/A FEDERATED HERMES, INC. reports a 0% stake in OTONOMY, INC.
08/09/2022 8-K Cost Associated with Exit or Disposal Activities, Departure of Directors or Certain Officers; Election of Directors; Appointm...
08/02/2022 SC 13G Point72 Asset Management, L.P. reports a 9.6% stake in Otonomy, Inc.
08/01/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Otonomy Reports Results from Phase 2 Clinical Trial of OTO-313 in Patients with Tinnitus • OTO-313 demonstrated no clinically meaningful improvement versus placebo for primary and secondary endpoints across all timepoints • Company to discontinue development of OTO-313 and implement other measures to extend its cash runway • Clinical focus shifts to OTO-413 following positive Phase 2a results in April 2022; top-line results for evaluation of higher dosing still expected in fourth quarter of 2022 SAN DIEGO, August 1, 2022"
07/25/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/25/2022 8-K Quarterly results
06/23/2022 8-K Quarterly results
05/09/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/09/2022 8-K Quarterly results
04/28/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/22/2022 SC 13G Weber David Allen reports a 5% stake in Otonomy, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy